Unaudited financial results for the quarter and half year ended September 30, 2025.
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fermenta Biotech's Board, at its November 11, 2025 meeting, approved unaudited standalone and consolidated financial results for Q2 FY26 and H1 FY26. Statutory auditor SRBC & Co LLP issued clean (unmodified) limited review reports on both sets of results. On a standalone basis, Q2 FY26 total income was about ₹112.6 crores and PAT around ₹14.7 crores, down from roughly ₹127.9 crores and ₹16.2 crores in Q2 FY25 — a YoY decline of about 12% in revenue and 9% in profit. For H1 FY26, consolidated total income was about ₹280.7 crores and consolidated PAT approximately ₹36.4 crores, sharply higher than H1 FY25. Standalone H1 FY26 PAT was about ₹31 crores. The strong H1 picture is helped by a one-time reversal of an inventory provision of ₹505.55 lakhs and gains on sale of investment property (about ₹163 lakhs). Separately, the Board approved the transfer of the Company's Environment Division as a going concern on a slump sale basis to its wholly-owned subsidiary Fermenta Environment Solutions Private Limited, effective October 1, 2025.
Q2 FY26 core numbers softened year-on-year, but H1 FY26 shows a sharp jump that is partly powered by one-time items and the Environment Division divestment. Going forward, the standalone entity will be leaner and more focused, which should make like-for-like comparisons easier but may reduce the standalone revenue base.